IN8bio (INAB) announced new clinical data from the ongoing Phase 1 investigator-sponsored trial of INB-100, an allogeneic gamma-delta T cell ...

CEMATRIX announces that it has won $5.8 million in new contract awards. These awards are split between executed contracts and contracts in process. Significant awards as part of the $5.8 total include ...